Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

DAPD and L-FMAU compared for in vitro anti-HBV activity using wild-type and resistant strains

Nov. 16, 1999

Safety and preliminary efficacy of HBV/MF59 vaccine: data presented at AASLD

Nov. 16, 1999

Beta-L-FD4C compared to lamivudine in woodchuck model of chronic HBV infection

Nov. 16, 1999

FR-167653 examined in rat model of hepatic ischemia/reperfusion injury

Nov. 15, 1999

rhIL-10 reduces liver injury, normalizes serum ALT in HCV patients failing interferon

Nov. 15, 1999

CDP-571 is effective in Crohn's disease: phase IIb study results announced

Nov. 15, 1999

AASLD presentations support feasibility of ribozyme therapy in HCV

Nov. 12, 1999

Phase II data support further study of VX-497 for hepatitis C

Nov. 12, 1999

Preliminary phase II results promising for Maxamine in HCV

Nov. 11, 1999

Dainippon discloses new compounds useful for the treatment or prophylaxis of liver disease

Nov. 10, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...